Biosimilars in the United States may demonstrate higher discounts and cost reduction than current estimates.
Benjamin Yu, PharmD
Advertisement
Articles by Benjamin Yu, PharmD
Advertisement
Latest Updated Articles
- Greater Potential Cost Savings With Biosimilar Use
Published: May 17th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5
